| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/16/2002 | US20020058625 Method for purifying factor vWF-complex by means of cation exchange chromatography |
| 05/16/2002 | US20020058623 Addition of cysteine delays the temporal decrease in the effective concentration of the protein. The process is suitable for use in the production of heterologous proteins in microorganisms. |
| 05/16/2002 | US20020058610 DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques; inhibiting such polypeptide for preventing and/or treating neoplasia; diagnostic assays |
| 05/16/2002 | US20020058324 Protein recovery |
| 05/16/2002 | US20020058322 DNA molecules encoding fibrinolytically active polypeptide |
| 05/16/2002 | US20020058311 Genetically engineered dietetic protein for use in treatment of diabetes, atherosclerosis, hypertension and eating disorders |
| 05/16/2002 | US20020058309 Nucleotide sequences for use in the treatment of nervous system disorders and neuronal damage |
| 05/16/2002 | US20020058303 Enhanced in vitro synthesis of active proteins containing disulfide bonds |
| 05/16/2002 | US20020058288 Compound for use in the detection and prevention of parasitic infection of humans |
| 05/16/2002 | US20020058274 Rapidly degrading GFP-fusion proteins and methods of use |
| 05/16/2002 | US20020058264 Human regulatory molecules |
| 05/16/2002 | US20020058257 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 05/16/2002 | US20020058251 Observing the distribution of MN/CA9 antigen expressed on atypical or normal cells; atypical glandular cells of undetermined significance (AGUS) |
| 05/16/2002 | US20020058036 Novel fibroblast growth factor and nucleic acids encoding same |
| 05/16/2002 | US20020058024 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 05/16/2002 | US20020058022 Novel compounds |
| 05/16/2002 | DE10054516A1 Extrudiertes Proteinhydrolysat, Verfahren zu dessen Herstellung und dessen Verwendung Extruded protein hydrolyzate, process for its preparation and its use |
| 05/16/2002 | CA2428453A1 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | CA2428368A1 Kit and method for detecting the esm-1 protein |
| 05/16/2002 | CA2428242A1 Human tumor necrosis factor receptor |
| 05/16/2002 | CA2428114A1 Apolipoprotein analogues |
| 05/16/2002 | CA2428055A1 Process for the preparation of latent antithrombin iii |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2426035A1 Streptavidin-binding peptides and uses thereof |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/16/2002 | CA2399276A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/15/2002 | EP1205547A2 DNA mutagenesis by random fragmentation and reassembly |
| 05/15/2002 | EP1205546A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1204855A1 Real-time, in situ biomanufacturing process monitoring and control in response to ir spectroscopy |
| 05/15/2002 | EP1204764A2 Methods of screening for angiogenesis modulators |
| 05/15/2002 | EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 05/15/2002 | EP1204752A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204747A1 G protein-coupled receptor expressed in brain |
| 05/15/2002 | EP1204744A1 Isolated peptide of the horny layer and use thereof |
| 05/15/2002 | EP1204738A1 A method for decreasing the foam formation during cultivation of a microorganism |
| 05/15/2002 | EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 05/15/2002 | EP1204682A2 Compositions and methods for the treatment of tumors |
| 05/15/2002 | EP1204681A2 Helical cytokine zalpha48 |
| 05/15/2002 | EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 05/15/2002 | EP0750509B1 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 05/15/2002 | EP0633941B1 Synthetic eukaryotic promoters containing two inducible elements |
| 05/15/2002 | CN1349559A Noninvasive detection of colorectal cancer and other gasrointestinal pathology |
| 05/14/2002 | US6388068 Nucleotide sequences of promoters; for efficient industrial production of exogenous polypeptides in plant xylem sap |
| 05/14/2002 | US6388065 DNA for evaluating the progression potential of cervical lesions |
| 05/14/2002 | US6388064 Human 2-19 protein homologue, z219a |
| 05/14/2002 | US6388056 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 05/14/2002 | US6388055 Mouse CC-CKR5 receptor polypeptide |
| 05/14/2002 | US6388052 Amino acid sequence of nuclear factor of activated t lymphocytes, a transcription factor; immunomodulators |
| 05/14/2002 | US6387875 Method of use for murine leukaemia inhibitory factor-binding protein (mLBP) |
| 05/14/2002 | US6387698 Polyclonal antiserum produced by immunzing animal with tumor rejection antigen precursor |
| 05/14/2002 | US6387682 Amino acid sequence of polypeptide with cysteine protease activity; treatment of bone disorders such as osteoporosis; anticarcinogenic agents; antitumor agents; antimetastasis agents |
| 05/14/2002 | US6387676 Human cDNAs encoding polypeptides having kinase functions |
| 05/14/2002 | US6387674 Has activity against betal amyloid 1-42 protein in beta sheet conformation; treatment of alzheimer's disease amyloidosis, atherosclerosis, and creutzfeld-jakob disease |
| 05/14/2002 | US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents |
| 05/14/2002 | US6387662 Constructing recombinant dna encoding core protein, envelope 1 protein, and envelope 2 protein; expressing dna in eukaryotic host cell and allowing assembly; then isolating non-infectious particle |
| 05/14/2002 | US6387658 PCNA-associated cell cycle proteins, compositions and methods of use |
| 05/14/2002 | US6387657 Amino acid sequence of wnt-1-induced secreted protein; anticarcinogenic agents; antitumor agents; treatment of arteriosclerosis; diagnosis of related disorders |
| 05/14/2002 | US6387638 Heregulin variants |
| 05/14/2002 | US6387627 Phagemid for antibody screening |
| 05/14/2002 | US6387616 Torsin, torsin genes, and methods of use |
| 05/14/2002 | US6387377 Acellular antibordetella vaccine |
| 05/14/2002 | US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells |
| 05/14/2002 | CA2249180C Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides |
| 05/14/2002 | CA2241210C Novel process for preparing n-acetyl(l)-4-cyanophenylalanine ac-(l)-phe(4-cn)-oh and n-acetyl-(l)-p-amidinophenylalanine-cyclohexylglycine-.beta.-(3-n-methylpyridinium)-alanine ac-(l)-paph-chg-palme(3)-nh2 |
| 05/14/2002 | CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/10/2002 | WO2002036807A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036802A1 Method for producing protein hydrolysate |
| 05/10/2002 | WO2002036801A2 Extruded protein hydrolysate, method for production and use thereof |
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036785A1 Protein complexes and process for producing the same |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036763A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof |
| 05/10/2002 | WO2002036762A1 Process for producing peptide |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036160A2 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/10/2002 | WO2002015927A8 High mannose proteins and methods of making high mannose proteins |
| 05/10/2002 | WO2002014468A3 Phage-dependent superproduction of biologically active protein and peptides |
| 05/10/2002 | WO2002000885A9 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 05/10/2002 | WO2001098338A3 Fluorescent proteins |
| 05/10/2002 | WO2001092337A3 Soluble ctla4 mutant molecules and uses thereof |
| 05/10/2002 | WO2001090304A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001087931A3 Bacterial insecticidal proteins |
| 05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |
| 05/10/2002 | WO2001083771A3 Human phospholipase c delta 5 |
| 05/10/2002 | WO2001083750A3 Dendritic cell co-stimulator molecules |
| 05/10/2002 | WO2001074845A3 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof |
| 05/10/2002 | WO2001072959A3 Plastid transformation vectors for expressing human proteins in plants |
| 05/10/2002 | WO2001066778A3 Production of foreign polypeptides in plants as viral coat protein fusions |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066573A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001062779A3 New transcription factor carp-2 |
| 05/10/2002 | WO2001047963A3 Inhibitors of complement activation, their preparation and use |
| 05/10/2002 | WO2001042472A3 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 05/10/2002 | WO2001042451A3 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS |